Sign in

CIK 0001178670

  • Large accelerated filer

ALNYLAM PHARMACEUTICALS, INC.

Sign in to watch
Ticker
ALNY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
770602661
Phone
+1 617-551-8200
Business address
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
Former names
ALNYLAM PHARMACEUTICALS INC
Open-market buys, last 90 days
$543,126
in 2 filings
Open-market sales, last 90 days
$398,855
in 1 filing

Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-20 MARAGANORE JOHN Chief Executive Officer Exercise or conversion +34,765 $9.14 $318K 224,758
2020-02-20 MARAGANORE JOHN Chief Executive Officer Sale −2,672 $128.62 $344K 222,086
2020-02-20 MARAGANORE JOHN Chief Executive Officer Sale −1,586 $129.33 $205K 220,500
2020-02-20 MARAGANORE JOHN Chief Executive Officer Sale −5,053 $131.07 $662K 215,447
2020-02-20 MARAGANORE JOHN Chief Executive Officer Sale −6,887 $131.61 $906K 208,560
2020-02-20 MARAGANORE JOHN Chief Executive Officer Sale −18,065 $132.81 $2.4M 190,495
2020-02-20 MARAGANORE JOHN Chief Executive Officer Sale −502 $133.42 $67K 189,993
2020-02-20 MARAGANORE JOHN Chief Executive Officer Exercise or conversion · Stock Option (right to buy) −34,765 104,295
2020-02-12 SHARP PHILLIP A Director Exercise or conversion +15,000 $15.82 $237K 250,633
2020-02-12 SHARP PHILLIP A Director Exercise or conversion +15,000 $9.14 $137K 265,633
2020-02-12 SHARP PHILLIP A Director Sale −30,000 $130.00 $3.9M 235,633
2020-02-12 SHARP PHILLIP A Director Exercise or conversion · Non-Qualified Stock Option (right to buy) −15,000 0
2020-02-12 SHARP PHILLIP A Director Exercise or conversion · Stock Option (right to buy) −15,000 0
2020-02-10 KEATING LAURIE EVP, Chief Legal Officer Exercise or conversion +10,000 $77.40 $774K 22,258
2020-02-10 KEATING LAURIE EVP, Chief Legal Officer Sale −10,000 $129.00 $1.3M 12,258
2020-02-10 KEATING LAURIE EVP, Chief Legal Officer Exercise or conversion · Stock Option (right to buy) −10,000 52,000
2020-01-27 KEATING LAURIE EVP, Chief Legal Officer Exercise or conversion +3,663 $77.40 $284K 12,258
2020-01-03 Poulton Jeffrey V. Chief Financial Officer Other acquisition +19 19
2019-10-10 Poulton Jeffrey V. Chief Financial Officer Other acquisition +38 38
2017-05-31 Sanofi 10% owner Purchase +297,501 $71.87 $21.4M 10,554,134

Page 79 of 80 · 1,590 trades